đ NEWS:Â Curebase raises its $15M Series A led by GGVÂ Capital. Read about it in Crunchbase, FierceBiotech, and MedCity News.
For certain study designs and sponsor types, Curebase can lead projects start to finish. We have unique experience in digital therapeutics, diagnostics, medtech products, observational data studies, and large-scale biospecimen collection.
Converted an IBS digital therapeutic study to fully at-home model after COVID-19 struck in just 2 days
Managed geriatric patients in a complex at-home study with mobile phlebotomy, smart devices, and weekly surveys
Validated a womenâs health diagnostic using a nationwide network
of 10 local HCPs
Running an oncology diagnostic study with tumor and outcomes collection
with no onsite travel
